Cancer prevalence is the proportion of people in a population diagnosed with cancer in the past and still alive. One way to estimate prevalence is via population-based registries, where data on diagnosis and life status of all incidence cases occurring in the covered population are collected. In this paper, a method to estimate the complete prevalence and its variance from population-based registries is presented. In order to obtain unbiased estimates of the complete prevalence, its calculation can be thought as made by three steps. Step 1 counts the incidence cases diagnosed during the period of registration and still alive. Step 2 estimates the expected number of survivors among cases lost to follow-up. Step 3 estimates the complete preva...
(NAACCR) sought objective estimates of the completeness of cancer registration among member registri...
BACKGROUND: Information on cancer prevalence is of major importance for health planning and resou...
Background: Accurate cancer incidence data are needed to plan, monitor and evaluate national cancer ...
Cancer prevalence is an important measure of the burden of the disease in a population and on the he...
Cancer prevalence is the proportion of people in a population diagnosed with cancer in the past and ...
Cancer prevalence is the proportion of a population diagnosed with cancer. We present a method for d...
Cancer prevalence is the proportion of individuals in a population who at some stage during their li...
Cancer incidence and mortality statistics provide limited insight regarding the cancer survivor popu...
IntroductionComparable indicators on complete cancer prevalence are increasingly needed in Europe to...
Cancer prevalence is the proportion of individuals in a population who at some stage during their li...
This paper describes the usage and the performance evaluation of the completeness index method in th...
The comparison of cancer prevalence with cancer mortality can lead under some hypotheses to an estim...
Background Population-based cancer registries are required to calculate cancer incidence in a geogr...
Background: Complete cancer prevalence data in Europe have never been updated after the first estima...
Objective. Use of cancer cases from registries and PMSI claims database to estimate Département-spec...
(NAACCR) sought objective estimates of the completeness of cancer registration among member registri...
BACKGROUND: Information on cancer prevalence is of major importance for health planning and resou...
Background: Accurate cancer incidence data are needed to plan, monitor and evaluate national cancer ...
Cancer prevalence is an important measure of the burden of the disease in a population and on the he...
Cancer prevalence is the proportion of people in a population diagnosed with cancer in the past and ...
Cancer prevalence is the proportion of a population diagnosed with cancer. We present a method for d...
Cancer prevalence is the proportion of individuals in a population who at some stage during their li...
Cancer incidence and mortality statistics provide limited insight regarding the cancer survivor popu...
IntroductionComparable indicators on complete cancer prevalence are increasingly needed in Europe to...
Cancer prevalence is the proportion of individuals in a population who at some stage during their li...
This paper describes the usage and the performance evaluation of the completeness index method in th...
The comparison of cancer prevalence with cancer mortality can lead under some hypotheses to an estim...
Background Population-based cancer registries are required to calculate cancer incidence in a geogr...
Background: Complete cancer prevalence data in Europe have never been updated after the first estima...
Objective. Use of cancer cases from registries and PMSI claims database to estimate Département-spec...
(NAACCR) sought objective estimates of the completeness of cancer registration among member registri...
BACKGROUND: Information on cancer prevalence is of major importance for health planning and resou...
Background: Accurate cancer incidence data are needed to plan, monitor and evaluate national cancer ...